These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1142 related items for PubMed ID: 3287933

  • 1. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D, Godsland IF, Wynn V.
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [Abstract] [Full Text] [Related]

  • 2. The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
    Godsland IF, Crook D, Simpson R, Proudler T, Felton C, Lees B, Anyaoku V, Devenport M, Wynn V.
    N Engl J Med; 1990 Nov 15; 323(20):1375-81. PubMed ID: 2146499
    [Abstract] [Full Text] [Related]

  • 3. The metabolic impact of oral contraceptives.
    Krauss RM, Burkman RT.
    Am J Obstet Gynecol; 1992 Oct 15; 167(4 Pt 2):1177-84. PubMed ID: 1415443
    [Abstract] [Full Text] [Related]

  • 4. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V.
    Contracept Fertil Sex (Paris); 1985 Jan 15; 13(1 Suppl):425-30. PubMed ID: 12280210
    [Abstract] [Full Text] [Related]

  • 5. Insulin resistance, secretion, and metabolism in users of oral contraceptives.
    Godsland IF, Walton C, Felton C, Proudler A, Patel A, Wynn V.
    J Clin Endocrinol Metab; 1992 Jan 15; 74(1):64-70. PubMed ID: 1530790
    [Abstract] [Full Text] [Related]

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G, Powell M, Marshall A, Woutersz TB, Steiner G.
    Int J Fertil Menopausal Stud; 1994 Jan 15; 39(5):283-91. PubMed ID: 7820162
    [Abstract] [Full Text] [Related]

  • 7. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
    Godsland IF, Crook D, Devenport M, Wynn V.
    Contraception; 1995 Sep 15; 52(3):143-9. PubMed ID: 7587185
    [Abstract] [Full Text] [Related]

  • 8. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
    Derman RJ.
    Postgrad Med; 1990 Sep 15; 88(4):119-22. PubMed ID: 2204902
    [Abstract] [Full Text] [Related]

  • 9. Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease.
    Gaspard UJ, Lefebvre PJ.
    Am J Obstet Gynecol; 1990 Jul 15; 163(1 Pt 2):334-43. PubMed ID: 2196805
    [Abstract] [Full Text] [Related]

  • 10. The role of triphasic levonorgestrel in oral contraception: a review of metabolic and hemostatic effects.
    Lachnit-Fixson U.
    Gynecol Endocrinol; 1996 Jun 15; 10(3):207-18. PubMed ID: 8862497
    [Abstract] [Full Text] [Related]

  • 11. Contraception for women with diabetes: an update.
    Skouby SO, Mølsted-Pedersen L, Petersen KR.
    Baillieres Clin Obstet Gynaecol; 1991 Jun 15; 5(2):493-503. PubMed ID: 1954724
    [Abstract] [Full Text] [Related]

  • 12. Coronary heart disease risk markers in users of low-dose oral contraceptives.
    Godsland IF, Crook D, Wynn V.
    J Reprod Med; 1991 Mar 15; 36(3 Suppl):226-37. PubMed ID: 2046076
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Mar 15; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

  • 16. Effects of desogestrel on carbohydrate metabolism.
    Shoupe D.
    Am J Obstet Gynecol; 1993 Mar 15; 168(3 Pt 2):1041-7. PubMed ID: 8447358
    [Abstract] [Full Text] [Related]

  • 17. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
    Gaspard UJ, Buret J, Gillain D, Romus MA, Lambotte R.
    Contraception; 1985 Apr 15; 31(4):395-408. PubMed ID: 3159546
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Update on the metabolic effects of steroidal contraceptives.
    Sondheimer SJ.
    Endocrinol Metab Clin North Am; 1991 Dec 15; 20(4):911-23. PubMed ID: 1778182
    [Abstract] [Full Text] [Related]

  • 20. Comparative metabolic effects of three types of combined oral contraceptive pills in Chinese women.
    Prasad RN, Liew D, Ratnam SS.
    Contraception; 1989 Jan 15; 39(1):21-35. PubMed ID: 2521321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.